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The origin recognition complex (ORC) was initially discov-
ered in budding yeast extracts as a protein complex that binds
with high affinity to autonomously replicating sequences in an
ATP-dependent manner. We have cloned and expressed the
human homologs of theORC subunits as recombinant proteins.
In contrast to other eukaryotic initiators examined thus far,
assembly of human ORC in vitro is dependent on ATP binding.
Mutations in the ATP-binding sites of Orc4 or Orc5 impair
complex assembly, whereas Orc1 ATP binding is not required.
Immunofluorescence staining of human cells with anti-Orc3
antibodies demonstrate cell cycle-dependent association with a
nuclear structure. Immunoprecipitation experiments show that
ORC disassembles as cells progress through S phase. The Orc6
protein binds directly to the Orc3 subunit and interacts as part
of ORC in vivo. These data suggest that the assembly and disas-
sembly of ORC in human cells is uniquely regulated and may
contribute to restricting DNA replication to once in every cell
division cycle.
Studies on themechanism of initiation of DNA replication in
budding yeast led to the identification of the six-subunit origin
recognition complex (ORC)3 that interacts with and licenses
origins of replication prior to S phase (1, 2). The human
homologs of the six ORC subunits have been identified and
have been shown to interact with each other to form various
complexes, suggesting that the licensing function of ORC may
be conserved in humans (3–13). Budding yeast ORC binds with
moderate affinity and sequence specificity to the autonomously
replicating sequences consensus sequence at origins of DNA
replication in yeast (14). The identification of specific DNA
sequences that define origins of replication in the human
genome has not been possible so far, and we sought to generate
a biochemical system that would allow us to isolate and test
putative DNA sequences that may function as the replicator
sequences in human cells. As a first step toward this goal, we set
out to establish protocols for the reconstitution of humanORC
using a completely recombinant system, using baculovirus
expression vectors.
The baculovirus expression system has been used success-
fully to generate recombinant six-subunit assemblies in insect
cells, expressing ORC proteins native to Saccharomyces cerevi-
siae, Schizosaccharomyces pombe, and Drosophila melano-
gaster (15–17). Work from several groups has shown that
human Orc1–Orc5 proteins interact with each other in vivo
and can also form a complex in insect cells (6, 8, 9, 11); however,
in these experiments, human Orc6 did not associate stoichio-
metrically. The interactions between human ORC subunits
have been mapped, and complex architecture was proposed
based on binary interactions between subsets of proteins co-
expressed in insect cells (8, 10). A recent report showed that
ATP plays a role in humanORC assembly, and anOrc4 protein
with a mutation in the Walker A motif forms unstable com-
plexes (8). This result was inconsistent with another report that
performed a similar analysis and showed no effect on complex
assembly when Orc1, Orc4, and Orc5 subunits had mutations
that should have impaired ATP binding (9). We have per-
formed similar experiments independently and have examined
the nucleotide requirements for ORC assembly.
Three of the six ORC subunits (Orc1, Orc4, and Orc5) have
been classified as typical AAA ATPases based on consensus
motifs found in their primary sequence (12, 13, 18–20). More-
over, although they do not possess consensus ATP-binding
motifs, Orc2 and Orc3 are also proposed to have an AAA
structure (21, 22). ATP binding has been primarily implicated
in the DNA binding activity of ORC in different systems. It is
essential in budding yeast ORC (2, 22–24), and mutations in
ScOrc1 that impair ATP binding result in loss of DNA binding
(22, 23). The ScOrc4 protein does not have a typical Walker A
motif. Corresponding mutations in ScOrc5 result in a temper-
ature-sensitive growth phenotype (23, 25, 26) without a signif-
icant effect on the initiation of DNA replication, and it was thus
proposed that ATP binding by yeast Orc5 has a role in chromo-
some integrity (26). Drosophila ORC requires ATP binding by
Orc1 for its DNA binding activity, whereas mutations in the
ATP-binding sites ofDmOrc4 orDmOrc5 have no effect on the
formation of ORC/DNA complexes (27). Human Orc1/Orc2/
Orc3/Orc4/Orc5 complexes containing Walker A mutants of
Orc1, Orc4, or Orc5 were compared with wild type in a recent
study (9). Thesemutant complexes were found to have reduced
DNA binding activity in vitro and were also unable to support
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sperm DNA replication in XlORC-depleted Xenopus extracts
(9). Thus, ATP is essential for ORC function in all systems
examined so far.
The stable association of humanOrc6with theORCcomplex
has been difficult to demonstrate so far, and only trace amounts
are observed within complexes after overexpression (6–11).
Interactions have been shown betweenOrc6 andORC subunits
by yeast two-hybrid analysis (28). The humanOrc6 protein was
identified on the basis of sequence homology to theDrosophila
Orc6 protein, but the human and fly homologs share little
sequence similarity with the budding yeast protein (7, 17). The
reconstitution of Drosophila ORC showed that Orc6 interacts
with the complex and promotes its DNA binding activity in
vitro (17, 27). Overexpression of human Orc6 with Orc2 or
Orc3 in the insect cell system results in a very weak interaction
(11); however, no data have been presented to date showing a
stable interaction between humanORC andOrc6 in vivo. Small
interfering RNA-mediated reduction of Orc6 protein levels in
human cells surprisingly resulted in a primary defect in cytoki-
nesis, whereas a defect in DNA replication was only observed
when all of the detectable Orc6 was lost from the cells (29).
Moreover, Orc6 in human cells binds to kinetochores during
mitosis (29). These observations raise the question whether
humanOrc6has evolved to have different roles during cell cycle
progression. As a first step toward addressing these questions,
we have raisedmonoclonal antibodies against the Orc6 protein
and demonstrated the association ofOrc6withORC in vivo and
in vitro.
In the present study, we have reconstituted the human ORC
using a baculovirus expression system and present evidence
that ATP is essential for human ORC assembly in vitro. We
have performed pulldown assays to address complex formation
and examined the role of ATP binding byOrc1, Orc4, andOrc5
in complex assembly. We have raised new antibodies against
different ORC subunits and examined their association in vivo
across the cell cycle. Based on these results, we present a model
for ORC assembly and disassembly that is consistent with pub-
lished data from different groups and that suggests a unique
mode of regulation for ORC in human cells when compared
with ORC from other species.
EXPERIMENTAL PROCEDURES
Expression Vectors and Mutagenesis—The following baculo-
viruses expressing recombinant proteins were gifts from Hel-
ena Yang and Sujit Dike: Orc1, His6-Orc2, HA-Orc3, Orc4,
Orc5, and Orc6. All constructs had been sequenced to ensure
that no errors had been introduced during amplification.
The different ORC subunits were cloned into pCITE-2a
(Novagen) for in vitro transcription and translation under the
control of a T7 promoter. Vectors expressing wild type Orc2,
Orc3, and Orc4 were gifts from Helena Yang. His6-Orc2 was
PCR-amplified out of pFastBac-Orc2 using Herculase poly-
merase (Stratagene), digested with BamHI and SpeI, and
then cloned into the BamHI/XbaI sites of pCITE2a. Orc4
mutant vectors were subcloned after mutagenesis into the
BamHI/XhoI sites of pCITE2a. pLPC-T7 Orc5 was used as
template for mutagenesis, and then wild type and mutants
were subcloned into BamHI/XhoI sites of pCITE2a. The vec-
tors used were pCITE2a-hOrc1, pCITE2a-hOrc2, pCITE2a-
His6-hOrc2, pCITE2a-hOrc3, pCITE2a-hOrc4, pCITE2a-
hOrc5, and pCITE2a-hOrc6.
Site-directed mutagenesis was performed on Orc1, Orc4,
and Orc5, and sequences of oligonucleotides used to generate
mutants are available on request. 50 ng of cDNA was used as a
template with 125 ng each of the two different oligonucleotides
and then PCR-amplified in a 50-l reaction using Pfu Turbo
polymerase (Stratagene). The resulting PCR reaction was
digested for 1 h at 37 °C with restriction enzyme DpnI. 5 l of
the digested product was then transformed into XL10 Gold
Ultracompetent Escherichia coli cells (Stratagene). The next
day, colonies were picked, and miniprep DNA was prepared
and sequenced to verify that the PCR had introduced only the
desired changes.
Complex Assembly in Insect Cells—Insect cells (High-5 cells,
Invitrogen) were plated in T-175 flasks and infectedwith amix-
ture of baculoviruses expressing the differentORC subunits at a
multiplicity of infection 5–10. After incubation for 60–72 h
at 28 °C, cells were harvested, washed twice with PBS, and then
washed and incubated in hypotonic lysis buffer (20 mM KPO4,
pH 7.5, 5 mM KCl, 1.5 mM MgCl2, 5 mM -mercaptoethanol)
followed by Dounce homogenization with a B pestle (Kontes)
for 25–30 strokes to release nuclei. The nuclei were collected by
centrifugation at 9600 rpm in an SLA-600TC rotor. Proteins
were then extracted in nuclear extraction Buffer PK/50 (20 mM
KPO4, pH 7.5, 50 mM KCl, 0.02% Nonidet P-40, 10% glycerol, 5
mM -mercaptoethanol, protease inhibitors (Complete EDTA-
free from Roche Applied Science), and 5 mM magnesium ace-
tate and 2 mM ATP where indicated). Solid ammonium sulfate
powder was added to 10% saturation to aid release of chroma-
tin-bound proteins. Human ORC subunits were precipitated
next by saturation at 45% ammonium sulfate. For the complex
assembly experiments, 300-l aliquots of protein were incu-
bated with 100 l of Talon resin (Clontech) that was pre-equil-
ibrated in Buffer PK/50. The resin was incubated with the
extract for at least 2 h at 4 °C. The resin was then washed with a
series of buffers: 2 Buffer PK/100 (containing 100 mM KCl)
and then 2Buffer PK/300, 2Buffer PK/100. All wash buffers
were supplemented with 10 mM imidazole. The proteins were
eluted in Buffer PK/100 containing 100mM imidazole. Aliquots
of each step of the purification were separated on a 10% dena-
turing polyacrylamide gel by SDS-PAGE.
Complex Assembly in Rabbit Reticulocyte Lysates—To gen-
erate [35S]methionine-labeled proteins, a 50-l reaction mix-
ture was set up as described by the TNT-coupled reticulocyte
lysate system (Promega). 1.5 g of plasmid DNA was used as a
template for transcription. [35S]methionine-Redivue was pur-
chased from Amersham Biosciences. The reaction was incu-
bated at 30 °C for 90 min to generate radioactively labeled pro-
tein. After translation was complete, it was diluted in binding
Buffer HN/150 (20 mM HEPES-NaOH, pH 7.5, 150 mM NaCl,
0.02% Nonidet P-40, 5 mM magnesium acetate, 5 mM -mer-
captoethanol, 10% glycerol, 10 mM imidazole, 1 mM ATP), and
incubated for 2 h at 4 °C with Talon resin (Clontech). After
binding, the resin was washed in Buffer HN/250 (i.e. binding
buffer butwith 250mMNaCl) and elutedwithBufferHN/150
100 mM imidazole. The eluates were separated by SDS-PAGE,
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and the gels were dried and exposed to a phosphorimaging
screen (Fuji). The screen was then processed in a FLA-5100
imaging system (Fuji) to visualize the proteins.
Purification of Recombinant Orc1—Orc1401–861 was ampli-
fied by PCR and cloned into pGEX-6P-1 (Amersham Bio-
sciences) for expression with an N-terminal glutathione
S-transferase (GST) tag. Competent E. coli BL21 (DE3) Codon
Plus strain (Stratagene)were transformedwith this plasmid and
grown on selective medium. The cells were grown in liquid
culture until they reached a density of OD 0.5–0.8 and then
induced to express protein by the addition of 0.4mM isopropyl-
-D-thiogalactoside (Roche Applied Science). Flasks were
transferred to 16 °C and grown for an additional 4–6 h. Cells
were collected by centrifugation, washed with PBS, and lysed in
Buffer HN/300 (20 mM HEPES-NaOH, pH 7.5, 300 mM NaCl,
0.02% Nonidet P-40, 5 mM magnesium acetate, 10% glycerol).
Lysis was aided by the addition of 200 mg/liter lysozyme
(Sigma) for 30min on ice. Lysateswere sonicated to shearDNA,
centrifuged at 14,000 rpm, and passed through a 0.45-m filter
to remove particulate material. The clarified supernatant was
then incubated with glutathione-Sepharose (Amersham Bio-
sciences) for 2 h at 4 °C to allow binding. The resin was washed
three times with 10 volumes each of lysis buffer, and protein
was eluted in HN/150  10 mM reduced glutathione (Sigma).
Protein was concentrated, snap-frozen in aliquots in liquid
nitrogen, and stored at80 °C. For purification of the different
GST-Orc1401–861 mutants, the buffer used was optimized for
maximal protein solubility and yield (20 mM KH2PO4, pH 7.5,
300 mM KCl, 0.02% Nonidet P-40, 10% glycerol, 5 mM magne-
sium acetate, 2 mM ATP, and 5 mM -mercaptoethanol). All
other steps were identical.
GST Pulldown Assays—4 g of purified protein (GST or
GST-hOrc1401–861) was diluted in pulldown assay buffer (25
mM Tris-Cl, pH 7.5, 50 mM KCl, 10% glycerol, 0.02% Nonidet
P-40. 0.1 mM EDTA, 5 mM magnesium acetate, 5 mM -mer-
captoethanol). Radioactively labeledORC subunits were gener-
ated using the TNT-coupled reticulocyte lysate system (Pro-
mega) and added to the reaction. The pulldown was done at
4 °C for 2 h, and resin with bound proteins was washed three
times in buffer containing 125mMKCl, boiled, and analyzed by
SDS-PAGE followed by phosphorimaging analysis. GST-Orc6
pulldowns were performed identically, except that the buffer
used 200 mM KCl throughout the experiment.
Cell Culture and Synchronization—Sf9 cells (ATCC) were
used to amplify and titrate baculovirus stocks. High-5 cells
(Invitrogen) were used to express recombinant protein. All
insect cells were cultured at 28 °C. Transient transfection
experiments were done in human embryonic kidney (HEK293)
cells cultured at 37 °C in a 5% CO2 environment.
For the cell cycle experiments, HeLa cells were grown in sus-
pension in spinner flasks at 37 °C. When cell density reached
1.0  105/ml, the culture medium was supplemented with 2.5
mM thymidine. Cells were incubated in thymidine for 14–16 h.
They were then washed with sterile PBS to remove excess thy-
midine, resuspended into fresh warm medium, and incubated
at 37 °C to initiate the first release. 10–12 h later, the culture
medium was supplemented with 2.5 mM thymidine once again
to set up the second block. Cells were synchronized at the G1/S
transition 14–16 h later. For time point t 0 h, aliquots of cells
were removed inmediumcontaining thymidine. For t 1h and
beyond, the cells werewashedwith sterile PBS to remove excess
thymidine, resuspended into fresh warm medium, and incu-
bated at 37 °C. For the experiment described in Fig. 6a, nocoda-
zole was added at a final concentration of 0.1 ng/ml to the cells
at 4 h after releasing from the second thymidine block. 2 106
cells were removed from synchronously cycling cells at the time
points indicated for immunoprecipitation.
For flow cytometry, 5  105 cells were collected for each
sample, washed with PBS, fixed in chilled (20 °C) methanol,
and stored overnight at 4 °C. Cells were then washed with PBS
and stained in PBS containing 25 g/ml propidium iodide
(Sigma) and 10 g/ml RNase A (Sigma) at 37 °C for 30 min.
Cells were analyzed for DNA content in an LSR-II cell analyzer
(BD Biosciences) using a 488-nm argon laser for excitation.
Data were captured and analyzed using the FACSCalibur soft-
ware (BD Biosciences).
Antibodies—Polyclonal antibodies were raised in New Zeal-
and White Rabbits (Covance) by injecting peptide antigens
coupled to activated KLH (Pierce). Antibodies used were: Orc1
(CS2117, antigen, VSQDDVLYALKDE), Orc3 (CS1890,
antigen, KKRKISLPIEDYFNKGK), Orc4 (CS1568, antigen,
KHLNDIYEEEPFNFQ), Orc4 (CS2100, antigen, GST-Orc4
protein), and Orc5 (CS1562, CS1569, antigen, KHHGKIKKT-
NFLKKHEKT). Antibodies were affinity-purified out of
serum using peptide coupled to a Sulfolink column (Pierce).
Antibodies against Orc2 and Orc6 have been described pre-
viously (4, 30).
Monoclonal antibodies were raised according to protocols
described previously (31). Antibodies were raised against Orc3
using the peptide antigen (KKRKISLPIEDYFNKGK) and
against Orc6 using recombinant GST-Orc6. Hybridomas were
screened by dot blot and enzyme-linked immunosorbent assay
analysis. Clones used in this study are PKS16-11 (Orc3) and
monoclonal antibody 6-30 (Orc6).
Cell Manipulations and Immunoprecipitation—For tran-
sient transfections, 10 g of plasmid DNAwas transfected into
HEK293 cells in a 10-cm plate using Lipofectamine 2000
(Invitrogen). Cells were harvested 24 h later, washed in PBS,
and extracted in lysis buffer (20 mM Tris-Cl, pH 7.5, 500 mM
KCl, 5 mM magnesium acetate, 0.1 mM EDTA, 1% Nonidet
P-40, 10% glycerol, 1 mM dithiothreitol) supplemented with
Complete EDTA-free protease inhibitor mixture (Roche
Applied Science), phosphatase inhibitors (10 mM sodium fluo-
ride, 1 mM sodium vanadate, 1 mM sodium -glycerophos-
phate) and 25 M MG-132 (Calbiochem). After incubation at
4 °C for 30min, the extractwas spun down, and the supernatant
was diluted to decrease the salt concentration to 250mmNaCl.
Antibodies used for immunoprecipitation were anti-FLAG
polyclonal (Sigma), anti-FLAG monoclonal M2 (Sigma), anti-
Orc3 monoclonal (PKS16-11), and anti-Orc3 polyclonal
(CS1890). Binding was done at 4 °C for 2 h, and immunopre-
cipitates were captured on Gamma Bind G-Sepharose resin
(Amersham Biosciences) and washed three times in wash
buffer (20 mM Tris-Cl, pH 7.5, 250 mM KCl, 5 mM magnesium
acetate, 0.1mMEDTA, 0.02%Nonidet P-40, 10% glycerol, 1mM
dithiothreitol) supplementedwithComplete EDTA-free prote-
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ase inhibitor mixture (Roche Applied Science), phosphatase
inhibitors (10 mM sodium fluoride, 1 mM sodium vanadate, 1
mM sodium -glycerophosphate). The resin was dried, resus-
pended in 100 l of Laemmli buffer, boiled, and analyzed by
SDS-PAGE followed by Western blotting. Immunoprecipita-
tion of Orc3 across the cell cycle was performed similarly with
the following modifications. MG-132 was omitted from the
lysis buffer, and in some experiments, the wash buffer used
contained 350 mM KCl.
Immunofluorescence—HeLa cells were grown on coverslips,
washed 3 in PBS, and fixed with 2% paraformaldehyde for 15
min at room temperature. After washing extensively with PBS,
membraneswere permeabilizedwith coldmethanol. Cells were
blocked in PBS  3% normal goat serum, and all staining and
washes were done in PBS  1% normal goat serum. Antibody
incubations were done for 1 h at room temperature in a humid-
ified chamber. Primary antibodies used were anti-Orc3 poly-
clonal antibody (CS1890 1:400) and anti-p150CAF-1 mono-
clonal antibody (SS1 1:400). Secondary antibodies were
Alexa Fluor 488-coupled anti-mouse or Cy5-conjugated anti-
rabbit (Molecular Probes). Thesewere both used at 1:1000 dilu-
tion. DNA was stained with 10 g/ml propidium iodide. Cells
were mounted in Vectashield (Vector Laboratories) and stored
at80 °C until ready for analysis.
To detect a fraction of protein that is tightly bound to the
nucleus, a previously described method was adapted (32). Cells
were washed in PBS and CSK buffer (10 mM PIPES, pH 7, 100
mMNaCl, 300mM Sucrose, 3 mMMgCl2) and then treated with
CSK  0.5% Triton X-100 to “pre-extract” the soluble non-
chromatin-bound pool of protein. Cells were then fixed in 2%
paraformaldehyde for 15 min at room temperature, treated
with coldmethanol for 5min, washed extensivelywith PBS, and
then blocked in PBS  3% normal goat serum. All following
steps were as described above.
Images were captured using a LSM 510 Meta confocal
microscope (Carl Zeiss MicroImaging Inc.) using the follow-
ing objectives: 20/NA 0.75 and 63/NA 1.4. Images were
processed using MetaMorph Software (version 6.1) and
assembled using Adobe PhotoShop (version 7.0) and Adobe
Illustrator (version 10).
RESULTS
ATP Supports the Association of Orc4 with Orc2, Orc3, and
Orc5—We chose to employ a baculovirus expression system
similar to those previously used to generate and characterize
the budding yeast and fly ORC complexes (15–17). Insect cells
were infected with a mixture of baculoviruses, each expressing
a different ORC subunit. The Orc2 virus was cloned with an
N-terminal histidine affinity tag, and the Orc3 virus was cloned
with an N-terminal hemagglutinin (HA) epitope tag for ease of
purification. Initial trials to generate a six-subunit ORC com-
plex showed inconsistent results, and there was varied expres-
sion and association of the Orc1 subunit, which was under-
represented relative to the Orc2, Orc3, Orc4, and Orc5
subunits (data not shown). The Orc6 protein was expressed in
significant quantities but did not associate in a stoichiometric
fashion under the conditions tested, similar to the results seen
by other groups (data not shown). We hypothesized that mere
co-expression of the different subunits was not enough to guar-
antee their assembly into stoichiometric complexes and that
association of the subunits may follow an ordered pathway. To
test this idea, we set out to analyze the assembly of smaller
complexes and to ask whether there was a specific pathway for
the addition of subunits to form higher order complexes.
High-5 cells were infected with baculoviruses expressing
His6-Orc2, HA-Orc3, Orc4, and Orc5. Nuclear extracts were
prepared from these cells and incubated with Talon resin
(Clontech) to capture His6-Orc2 and associated proteins. The
extracts were incubated either with or without 2 mM ATP, and
this condition was maintained in each sample over the entire
purification. TheTalon resinwaswashed extensively to remove
any proteins that were bound non-specifically. After eluting,
the proteins were separated by SDS-PAGE, stained with silver,
and developed to near equivalent intensity without saturating
the silver stain. As shown in Fig. 1a, the association of Orc4 was
significantly enhanced when the proteins were purified in the
presence of ATP (lanes E1 and E2) than in its absence (lane E).
The association between the Orc2, Orc3, and Orc5 subunits
was not visibly affected in the presence or absence of ATP,
suggesting that these three proteins form a complex independ-
ent of nucleotide. Gel filtration analysis of purified His6-Orc2/
HA-Orc3/Orc5 showed that the proteins had a peak elution
volume consistent with the formation of a heterotrimeric com-
plex with one subunit each (data not shown).
The effect of nucleotides other than ATP on complex assem-
bly was tested by performing parallel purifications in the pres-
ence of ATP, ADP, or ATPS (which is a non-hydrolyzable
triphosphate analog). Fig. 1b shows that millimolar concentra-
tions of ADP were unable to support the association of Orc4
with the Orc2/Orc3/Orc5 subcomplex (lane E), whereas
ATPS was efficient to a similar extent as ATP (lanes E and E2
respectively). These results suggest that a nucleoside triphos-
phate is required for the formation of a stableOrc2/Orc3/Orc4/
Orc5 complex.
To verify that the ATP-dependent assembly was not
restricted to proteins generated in insect cells, we set up the
following in vitro assembly assay for Orc2/Orc3/Orc4/Orc5
complex formation. The subunits were cloned into pCITE2a
(Novagen) for in vitro transcription and translation. Orc2,
Orc3, Orc4, and Orc5 were co-expressed in a single reaction
using a rabbit reticulocyte lysate system (Promega) and radio-
actively labeled using [35S]methionine (Amersham Bio-
sciences). Orc2 was expressed either as an untagged protein in
control reactions or as a His6-tagged protein in the test reac-
tion. Orc5 was expressed as a T7-tagged construct for efficient
incorporation of radioactive methionine label.
After co-expressing the Orc2–Orc5 proteins, they were
diluted in buffer containing 100 mM NaCl and incubated with
Talon resin, either with or without ATP, to capture His6-Orc2
and associated protein complexes. The Talon resin was then
washed extensively in parallel reactions with buffer containing
100, 250, or 500 mM NaCl to remove non-specifically bound
proteins. After elution with imidazole, proteins were separated
by SDS-PAGE and visualized by using a phosphorimaging sys-
tem (Fuji). Orc4 associated with Orc2/Orc3/Orc5 in an ATP-
dependent manner similar to that seen in the insect cell system
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(Fig. 1c). The interaction between Orc2, Orc3, and Orc5 was
stable up to 500 mM NaCl.
ATP Binding by Orc4 andOrc5 are Essential for Formation of
Orc2/Orc3/Orc4/Orc5 Complex—In the Orc2/Orc3/Orc4/
Orc5 complex, there are two subunits, namely Orc4 and Orc5,
that have the potential to bind ATP due to conservedWalker A
and Bmotifs. To test whether ATP binding by theOrc4 orOrc5
subunits was essential for complex formation, we generated a
series of mutants based on existing data on the corresponding
yeast and fly mutants as well as on structural data on AAA
proteins (5, 19, 23, 25, 27, 33). These mutants are indicated in
Fig. 2a. Mutations in the Walker A motif or the first half of the
Walker Bmotif of these proteins were predicted to disrupt ATP
binding, whereas mutations in the second half of the Walker B
motif were predicted to allow ATP binding but block ATP
hydrolysis (23). The association of Orc4 with Orc2/Orc3/Orc5
was tested in the presence of 1 mM ATP using such mutants of
Orc4 (Fig. 2b) or Orc5 (Fig. 2c) using the in vitro assembly assay
described above. Mutants designed to block ATP binding in
Orc4 (Fig. 2b, compare lanes 3–6 with lanes 13–16) and Orc5
(Fig. 2c, compare lanes 3–5 with lanes 11–13) show impaired
Orc4 association with Orc2/Orc3/Orc5. The Orc5 subunit
associated with Orc2 and Orc3 independent of the Orc5 muta-
tion status (Fig. 2c). Mutants designed to block ATP hydrolysis
(Fig. 2, b, lanes 7 and 17, and c, lanes 6 and 14) or in conserved
arginine residues predicted to make contact with the -phos-
phate (the sensor 1 motif; Fig. 2, b, lanes 8 and 9 and 18 and 19,
c, lanes 7 and 15) showed results similar towild type. Therefore,
we conclude that ATP binding by Orc4 and Orc5 are essential
for Orc2/Orc3/Orc4/Orc5 complex assembly in vitro. This
assay also reveals that Orc4 association in the complex is
ordered and is not favored in the absence of Orc5 even in the
presence of ATP (Fig. 2c compare lanes 2 and 10).
ATP Supports the Association of Orc1 with Orc2–Orc5—We
next tested the requirements for the formation of a stableOrc1/
Orc2/Orc3/Orc4/Orc5 complex. Recombinant baculoviruses
expressing Orc1, His6-Orc2, HA-Orc3, Orc4, and Orc5 were
co-infected into insect cells. Nuclear extracts were prepared
and incubated with Talon resin, either with or without ATP to
capture His6-Orc2 and associated protein complexes. In the
presence of ATP, a five-subunit Orc1/Orc2/Orc3/Orc4/Orc5
complex was purified (Fig. 3a). In the absence of ATP, levels of
Orc4 and Orc1 associated with the complex were significantly
reduced. Therefore, we conclude thatOrc1 associationwith the
complex is ATP-dependent and/or Orc4-dependent.
To address Orc1/Orc2/Orc3/Orc4/Orc5 complex assembly
in vitro, we set up a GST pulldown assay as follows. Orc2–Orc5
proteins were co-expressed in a rabbit reticulocyte lysate to
generate [35S]methionine-labeled proteins. These were diluted
FIGURE 1. ATP-dependent assembly of Orc2-Orc5. a, ATP supports the
association of Orc4 with Orc2/Orc3/Orc5 in insect cell extracts. Baculovi-
ruses expressing His6-Orc2, HA-Orc3, Orc4, and Orc5 were co-infected into
insect cells, and nuclear extracts from these cells were incubated with a
Talon resin to purify His6-Orc2 and associated complexes, either in the
presence or in the absence of ATP. Aliquots removed at various steps of
the purification were analyzed by SDS-PAGE followed by silver staining.
I input; F Flow through; WWash fractions; E elution fractions. E1
and E2 are samples purified in the presence of ATP, and E is the elution
fraction of an equivalent sample purified in the absence of ATP. b, ATPS
supports the assembly of Orc2–Orc5 similar to ATP, but ADP does not.
Baculoviruses expressing His6-Orc2, HA-Orc3, Orc4, and Orc5 were co-
infected into insect cells, and nuclear extracts from these cells were incu-
bated with a Talon resin to purify His6-Orc2 and associated complexes, in
the presence of ATP, ATPS, or ADP. Samples were processed as in panel a.
E2 is sample purified in the presence of ATP, E is an equivalent sample
purified in the presence of ATPS, and E is an equivalent sample purified
in the presence of ADP. c, the ATP-dependent association of Orc2–Orc5 is
recapitulated using in vitro transcribed and translated [35S]methionine-la-
beledproteins. UntaggedOrc2 (C) or His6-taggedOrc2 (H) were co-expressed
with Orc3, Orc4, and T7-Orc5 in a rabbit reticulocyte lysate, and resulting
complexes were purified using a Talon resin either in the presence () or in
the absence () of ATP. Three separate reactions were performed, with wash
buffer containing 100, 250, or 500 mM NaCl. Equivalent amounts of control
untagged Orc2 and His6-tagged Orc2 containing reactions were analyzed by
SDS-PAGE followed by phosphorimaging analysis.
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FIGURE 2.Analysis ofOrc2–5 complex assembly in vitro. a, schematic representation of Orc1, Orc4, andOrc5 showing the AAAmotifs andmutations used
in this study. The AAA domains of Orc1, Orc4, and Orc5 are shown as described (5). Positions of the different mutations analyzed in this study are indicated
by arrows. The small black box in all three constructs represents theWalker Amotif, and the small gray box represents theWalker Bmotif. The large N-terminal
non AAA region of Orc1 (amino acids 1–477) is shaded in gray. b, mutants of Orc4 that are predicted to disrupt ATP binding are impaired for Orc2–Orc5
assembly in rabbit reticulocyte lysates. His6-Orc2, Orc3, and T7-Orc5 were co-expressed in rabbit reticulocyte lysate with either wild type (WT) or mutant Orc4
constructs, and resulting complexes were isolated in the presence of 1 mM ATP using Talon resin. A reaction with untagged Orc2 was used to control for
nonspecific binding to the resin (lanes 1 and 11) andone lackingOrc4 to reveal thebands specific to theOrc4 reaction (lane 2). Input proteins are shown in lanes
1–9. Lanes 11–19 show the His6-Orc2 pulldown. Asterisks indicate bands that represent nonspecific or truncated products from the in vitro translation reaction.
c, mutants of Orc5 that are predicted to disrupt ATP binding are impaired for Orc2–Orc5 assembly in rabbit reticulocyte lysates. His6-Orc2, Orc3, andOrc4were
co-expressed in rabbit reticulocyte lysate with either wild type or mutant T7-Orc5 constructs, and resulting complexes were isolated in the presence of 1 mM
ATP using Talon resin. A reaction with untagged Orc2 was used to control for nonspecific binding to the resin (lanes 1 and 9), and one lacking Orc5 was used
to reveal thebands specific to theOrc5 reaction (lane 2). Inputproteins are shown in lanes 1–7, and thoseboundbyHis6-Orc2pulldownare shown in lanes 9–15.
Asterisks indicate bands that represent nonspecific or truncated products from the in vitro translation reaction.
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in buffer containing ATP, and the reaction was incubated with
glutathione-Sepharose resin containing either GST or a soluble
fragment of Orc1 (amino acids 401–861) expressed as a GST-
fusion protein. Preliminary experiments showed that a frag-
ment containing the AAA domain of Orc1 was sufficient for
complex assembly (data not shown). After a 2-h incubation to
allow complex formation, the resin was washed extensively to
remove non-specifically bound proteins, boiled in Laemmli
buffer, and analyzed by SDS-PAGE followed by phosphorimag-
ing analysis. The results in Fig. 3b show that GST-Orc1401–861
interacts stably with Orc2/Orc3/Orc5 only when Orc4 is
included in the reaction and very weakly in its absence. There-
fore, we conclude that Orc1 interacts weakly with the Orc2/
Orc3/Orc5 complex and that the formation of a stable Orc1/
Orc2/Orc3/Orc4/Orc5 complex is Orc4-dependent.
Contribution of ATP Binding by the AAA Subunits in Orc1/
Orc2/Orc3/Orc4/Orc5 Complex Assembly in Vitro—We tested
the requirement for ATP binding by Orc1, Orc4, and Orc5 for
Orc1/Orc2/Orc3/Orc4/Orc5 complex formation, introducing
mutants of only one subunit at a time in the GST pulldown
assay described above. Mutants of Orc1 were expressed as
GST-Orc1401–861 fusion proteins and tested for Orc2–Orc5
association in the presence of ATP. Mutations in Orc1 pre-
dicted to disrupt ATP binding or hydrolysis have no significant
impairment in complex formation in vitro (Fig. 4a). Thus, we
conclude that ATP binding byOrc1 is not essential for complex
formation and may have other roles in DNA replication.
Orc1/Orc2/Orc3/Orc4/Orc5 complex formation was then
assayed in the presence of wild type or mutant Orc4 subunits
using the GST pulldown assay (Fig. 4b). The data show that
Orc4 mutants that are impaired for ATP binding do not sup-
port the formation of Orc1/Orc2/Orc3/Orc4/Orc5 complexes.
Also, Orc1 does not interact well with Orc4 alone even in the
presence of ATP (lanes 1, 10, and 11). Therefore, Orc1 associ-
ation with Orc2–Orc5 requires ATP binding by Orc4 and sug-
gests that stable Orc1 interaction is dependent on the prior
formation of an Orc2/Orc3/Orc4/Orc5 complex.
Fig. 4c shows the results of Orc1/Orc2/Orc3/Orc4/Orc5
complex formation in the presence of mutant Orc5 subunits
using the GST pulldown assay. The data show that Orc5
mutants that are impaired for ATP binding form Orc1/Orc2/
Orc3/Orc4/Orc5 complexes with similar efficiency as the wild
type, in contrast to what was observed for Orc2–Orc5 forma-
tion (Fig. 2c). This result suggests that Orc5 ATP binding may
be essential for interaction of Orc5 with Orc4; however, the
presence of wild type Orc1 may bridge this interaction in the
mutants, stabilizing higher order complexes.
The C Terminus of Orc1 Containing the AAA Domain Is
Necessary and Sufficient for Complex Assembly in Vivo—The
Orc1/Orc2/Orc3/Orc4/Orc5 complex was assembled in vitro
using a truncated fragment of Orc1 lacking the N-terminal 400
amino acids (Fig. 3b). We decided to test what was the smallest
region of Orc1 that was required for complex formation in
human cells using the following assay. Full-lengthOrc1 or trun-
cated fragments (either N-terminal or C-terminal) were cloned
with a FLAG epitope tag in a plasmid vector under control of a
cytomegalovirus promoter (pLPC). These were overexpressed
in HEK293 cells by transient transfection. Fig. 5a shows a rep-
resentation of theOrc1 constructs used in this experiment. The
expressed Orc1 protein was stabilized by incubation of the
transfected cells with proteasome inhibitor, MG-132 (34).
Whole cell extracts were prepared from these cells and were
subject to immunoprecipitation using monoclonal antibodies
either against the FLAG epitope tag (M2-Sigma) or against
Orc3 (PKS16-11). The resulting immunoprecipitates were ana-
lyzed for the presence of Orc2–Orc5 subunits byWestern blot-
ting using polyclonal antibodies to these proteins. Orc1-FLAG
was detected using anti-FLAG polyclonal antibodies (Sigma).
Fig. 5b shows that anti-FLAG antibodies immunoprecipitated
all the different Orc1 constructs in similar quantities. However,
onlyOrc1401–861 andOrc1501–861 showed association ofOrc2–
Orc5 subunits comparable with full-length Orc1 (lanes
2–4). Truncation of an additional 100 amino acids of Orc1
FIGURE 3. Assembly of Orc1 into ORC in vitro. a, association of Orc1 with
Orc2/Orc3/Orc5 is ATP- and/or Orc4-dependent in insect cells. Baculoviruses
expressing Orc1, His6-Orc2, HA-Orc3, Orc4, and Orc5 were co-infected into
insect cells, and nuclear extracts from these cells were incubatedwith a Talon
resin to purify His6-Orc2 and associated complexes, either in the presence or
in the absence of ATP. Aliquots removed at various steps of the purification
were analyzed by SDS-PAGE followed by silver staining. I input; F Flow
through; W  Wash fractions; E  elution fractions. E1 and E2 are samples
purified in the presence of ATP, and E is the elution fraction of an equivalent
sample purified in the absence of ATP. b, association of Orc1 with Orc2/Orc3/
Orc5 is Orc4-dependent. Orc2, Orc3, and T7-Orc5were co-expressed in rabbit
reticulocyte lysates, either without (lane 1) or with (lane 2) Orc4. These were
mixed either with purified GST (C) or with GST-Orc1401–861 (O1) to test for
specific association with Orc1401–861 in the presence of 1 mM ATP.
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(Orc1601–861, lane 5) reduced the amount of co-precipitating
Orc2–Orc5 significantly. The N-terminal fragments of Orc1
lacking any AAAmotifs did not interact with Orc2–Orc5 in
this assay (lanes 6 and 7). Supporting these results, it is seen in
the Orc3 immunoprecipitates that the Orc1401–861 and the
Orc1501–861 associate with Orc3 similar to the full-length pro-
tein (lanes 10–12); however, Orc1601–861 as well as the N-ter-
minal fragments are compromised
for this interaction (lanes 13–15).
This result shows that a fragment
containing an intact AAA domain
of Orc1 is necessary and sufficient
for interaction with Orc2–Orc5 in
vivo and also validates the results
from the in vitro GST pulldown
assay using this fragment.
Interestingly, it was observed that
in the Orc3 immunoprecipitates,
Orc4 was significantly enhanced in
samples where Orc1, Orc1401–861,
and Orc1501–861 were overex-
pressed (Fig. 5b, lanes 10, 11, and
12). The corresponding levels of
Orc5 were only modestly increased,
whereasOrc2was unchanged. Total
levels of the Orc2–Orc5 subunits
were not increased as a result of
Orc1-FLAG overexpression when
compared with the untransfected or
vector control transfections, and
the input levels of Orc2–Orc5 in
these immunoprecipitates were
similar (data not shown). This result
suggests that Orc1 promotes or sta-
bilizes the association of Orc4 to
form higher complexes in vivo.
The Human Origin Recognition
Complex Disassembles during S
Phase—Based on the above obser-
vations, we hypothesized that Orc4
associationwithORCwould be pro-
moted in the presence of Orc1 sub-
unit during the cell cycle. Therefore,
during S phase, when Orc1 levels
are decreased due to ubiquitin-me-
diated proteolysis (34, 35), we pre-
dicted that Orc4 association with
Orc2–Orc5 would be decreased.
This idea was tested in the following
experiment. HeLa cells were syn-
chronized at the G1/S boundary
using a double thymidine block and
then released into fresh medium to
allow synchronous passage into S
phase. Samples were collected every
hour over a period of 10 h. Extracts
were prepared from these samples
and subjected to immunoprecipita-
tion using monoclonal antibodies directed either against the
Myc epitope tag as control (data not shown) or against Orc3.
The immunoprecipitates were examined for the different ORC
subunits by Western blotting as shown in Fig. 6a. The blots
show that total levels of Orc1 progressively decrease as the cells
passage through S phase consistent with its ubiquitin-mediated
proteolysis described previously (34). The total levels of Orc2,
FIGURE4.AnalysisofOrc1–Orc5complexassembly in vitro.a, associationofOrc1withOrc2/Orc3/Orc5does
not require ATP binding by Orc1. Orc2, Orc3, Orc4, and T7-Orc5 were co-expressed in rabbit reticulocyte
lysates, and the resulting complexes were tested for association with GST-Orc1401–861, either wild type (WT,
lane 3) or mutants (lanes 4–7), in the presence of 1 mM ATP. GST was used a control for nonspecific protein
association (lane 2). b, association of Orc1 with Orc2/Orc3/Orc5 is Orc4-dependent and requires a functional
ATP-binding site in Orc4. Orc2, Orc3, and T7-Orc5 were co-expressed in rabbit reticulocyte lysate either with
wild type or mutant Orc4 constructs. Input proteins are shown in lanes 3–9. The resulting complexes were
mixed eitherwith purifiedGST (C) orwithGST-Orc1401–861 (O) to test for specific associationwithOrc1401–861 in
the presence of 1mM ATP (lanes 14–27). As controls, Orc4 (lanes 1, 10, and 11) and Orc2/Orc3/T7-Orc5 (lanes 2,
12, and 13) were tested separately for associationwithOrc1401–861. c, association ofOrc1withOrc2/Orc3/Orc4/
Orc5 does not require ATP binding by Orc5. Orc2, Orc3, and Orc4 were co-expressed in rabbit reticulocyte
lysate either with wild type or mutant T7-Orc5 constructs. The input proteins are in lanes 3–8. The resulting
complexes were mixed either with purified GST or with GST-Orc1401–861 to test for specific association with
Orc1401–861 in the presence of 1 mM ATP (lanes 13–24). As controls, Orc5 or Orc4 and Orc4 were tested for
binding Orc1 (lanes 1, 2, and 9–12).
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Orc3, Orc4, and Orc5 remain relatively unchanged during this
period. In the Orc3 immunoprecipitates, the associated Orc2
and Orc5 remain constant throughout the cell cycle, in agree-
ment with the observation that they can form an ATP-inde-
pendent heterotrimer in vitro. However, levels of associated
Orc1 and Orc4 consistently decreased in parallel. This result
suggests that degradation of Orc1 is accompanied by a loss of
Orc4 association with the complex.
In the experiment described in Fig.
6a, nocodazole was added at 4 h
after release from the second thymi-
dine block to prevent cells from
entering the G1 phase of the next
cell cycle; however, similar results
were obtained in experiments when
cells were released in the absence of
the drug (data not shown).
Orc3 Levels Decrease in the Chro-
matin-enriched Fraction during S
Phase—The Orc1 subunit has been
implicated in the DNA binding
activity of human ORC (10). The
results above suggested that the
ORC disassembles across S phase,
concomitant with the degradation
of Orc1. We hypothesized that as a
consequence of Orc1 destruction,
the association of the remaining
ORC subunits with DNA may be
compromised. Supporting this
hypothesis, it had been previously
demonstrated that Orc2 was pro-
gressively diminished during S
phase when cells were extracted
with detergent prior to immunoflu-
orescence staining in HeLa cells
(30). We tested whether this was
true for the Orc3 subunit. Antibod-
ies against Orc3 (CS1890) showed a
uniform punctate nuclear signal in
cultured tumor cells (Fig. 6b). HeLa
cells were washed with PBS and
then fixed with paraformaldehyde,
or they were washed in parallel with
CSKbuffer containingTritonX-100
to remove soluble nuclear proteins
and then fixed and stained with
anti-Orc3 antibodies. This process
of pre-extraction of the cells with
detergent showed significant differ-
ences in the staining intensities of
the cells (Fig. 6b), suggesting that
Orc3 was more tightly bound to the
chromatin fraction in some cells
versus others. To test whether these
staining differences were cell cycle-
regulated, the cells were co-stained
with p150 CAF-1, a protein known
to localize to replication factories only visible during S phase in
tumor cells (36–40). The staining patterns of p150CAF-1
would thus facilitate distinction of cells in different stages of S
phase. In cells that did not score positive forCAF-1, the staining
intensities of propidium iodide facilitated the identification of
cells that were in G1 or late S/G2 phase of the cell cycle. The
results in Fig. 6c show that following pre-extractionwith Triton
FIGURE5.Mappingof theOrc1domain forORCcomplexassembly invivo.a, schematic representationof all
Orc1 (full-length and deletion) constructs used in the transient transfection experiments. Orc1 full-length and
deletion constructs were cloned with a C-terminal FLAG epitope tag. The AAA motifs are indicated by the
small boxes (blackWalker Amotif;grayWalker Bmotif). The largeN-terminal non-AAAdomain is shaded
in gray. The amino acids included in the constructs are indicated on the rightwith superscript. b, the C terminus
of Orc1 containing the AAA domain is necessary and sufficient for interaction with Orc2–Orc5 in vivo. The
constructs described in panel awere transfected into HEK293 cells, and extracts were prepared from these for
immunoprecipitation (IP), either using anti-FLAG (M2 Sigma) or using anti-Orc3 (PKS16 clone number 11)
monoclonal antibodies. Lanes 1–8 show the results of the immunoprecipitation using anti-FLAG antibodies,
and lanes 9–16 show the results using anti-Orc3 antibodies. The inputs for these immunoprecipitations show
similar levels for all proteins examined (data not shown). Lanes 1 and 9 empty vector control; lanes 2 and
10 Orc1-FLAG; lanes 3 and 11 Orc1401–861-FLAG; lanes 4 and 12 Orc1501–861-FLAG; lanes 5 and 13
Orc1601–861-FLAG; lanes 6 and 14  Orc11–400-FLAG; lanes 7 and 15  Orc11–500-FLAG; lanes 8 and 16 
untransfected cells.
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X-100, the Orc3 signal was higher in the cells showing early S
phase patterns but was reduced in cells showing mid-to-late S
phase patterns. From these data, we concluded that, as shown
previously for Orc2 (30), Orc3 was less tightly bound to nuclear
structures in later stages of S phase and may reflect its dissoci-
ation from chromatin. Such an analysis was not possible for
Orc4 and Orc5 because of a lack of suitable antibodies that
work well for immunostaining.
Orc6 Interacts with ORC Subunits in Vivo and in Vitro—The
human Orc6 protein was identified based on a high degree of
sequence similarity with the Drosophila homolog (6). Since
DmOrc6 participates in the formation of a six-subunit complex
(17), we hypothesized that the human Orc6 protein also inter-
acts with its cognate complex. Using polyclonal antibodies
againstOrc3,Orc4, andOrc5, nativeORCwas immunoprecipi-
tated from HEK293 nuclear extracts. Rabbit IgG was used as a
control to identify nonspecific interactions. All immunopre-
cipitates were examined for the presence of different ORC sub-
units by Western blotting. The results in Fig. 7a reveal that
three independent antibodies against Orc3 and Orc5 were able
to co-precipitate Orc6, but not antibodies directed against
Orc4 or Rabbit IgG. The ratio of the amount of protein brought
down in the immunoprecipitates when compared with the
input level was considerably lower for Orc6 when compared
with the ratios forOrc2, Orc3, andOrc4, suggesting that a large
fraction of Orc6 was not associated with the ORC complex. An
immunoprecipitation experiment was also performed using
monoclonal antibodies, either against Orc3 or against the Myc
epitope tag as a control. The different ORC subunits were ana-
lyzed by Western blotting with polyclonal antibodies (Fig. 7b).
Again, a small but specific signal for Orc6 was observed inOrc3
but not in control immunoprecipitates. A nonspecific protein
FIGURE 6.DissociationofORCduring Sphase. a, the humanorigin recognition complex disassembles in S phase inHeLa cells. HeLa cellswere arrested at the
G1/S transition by a double thymidine block protocol and then released into S phase by incubation in fresh medium. Aliquots of cells were harvested at 1-h
intervals and were examined for DNA content by staining with propidium iodide followed by flow cytometry (panel i) or used to prepare whole cell extracts
followed by immunoprecipitation (IP) using anti-Orc3 antibodies (panel ii). The Orc3 immunoprecipitates were analyzed for the presence of Orc1–Orc5
subunits by Western blotting. Inputs are shown in the top five panels, and corresponding immunoprecipitates are shown in bottom six panels. Two different
exposures for the Orc4 immunoprecipitates have been shown to highlight the decreasing signal in the later time points. The asterisks in the Orc2 immunoblot
denote nonspecific bands as verified previously by RNA interference analysis (Prasanth et al. 30). b, Orc3 staining patterns in HeLa cells with or without
treatment with Triton X-100 to reveal chromatin-bound protein. HeLa cells were stained with anti-p150 CAF1 monoclonal antibodies (SS1) and anti-Orc3
polyclonal antibodies (CS1890) eitherwithout pre-extraction (panels a–d) or followingpre-extractionwith CSKbuffer 0.5%TritonX-100 (panels a, b, c, and
d) Cells were co-stained with propidium iodide (panels c and c) to visualize DNA. Panels d and d show a merge of panels a and b and panels a and b,
respectively. All images have been captured using a20/NA 0.75 objective. c, chromatin-boundOrc3 shows higher signal in cells in early S phase than in cells
in mid-to-late S phase. HeLa cells were pre-extracted with CSK buffer  0.5% Triton X-100 and co-stained with anti-Orc3 polyclonal antibodies (red) and
anti-p150CAF1 monoclonal antibodies (green). The p150 CAF1 staining patterns reveal that cells in mid-to-late S phase show lower intensities of Orc3 signal
than cells in G1 or early S phase. Cells were co-stained with propidium iodide (blue) to visualize DNA. The last row shows a merge of all three channels.
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was present in both precipitates and may be the light chain of
IgG. Thus, we conclude that Orc6 interacts with the otherORC
subunits in a complex in human nuclear extracts.
To test whether Orc6 interacts directly with any ORC sub-
unit, a GST pulldown assay was performed as follows. Human
Orc1–Orc6 were expressed separately in a rabbit reticulocyte
lysate to generate [35S]methionine-labeled proteins. The pro-
teins were diluted in buffer and incubated either with purified
GST or with GST-Orc6 bound to glutathione-Sepharose. After
incubation for 2 h to allow stable protein interactions to form,
the resin was washed extensively to remove non-specifically
bound proteins. The bound proteins were then boiled and ana-
lyzed by SDS-PAGE followed by autoradiography. The results
demonstrate that GST-Orc6 specifically pulls down Orc3 (Fig.
7c). Thus, we present evidence that Orc6 associates with ORC
subunits both in vitro and in vivo and propose that Orc6may be
recruited to the complex by virtue of its interaction with Orc3.
DISCUSSION
Based on previous research on yeast and DrosophilaORC, it
was expected that the human ORC proteins would similarly
form a six-subunit complex (15–17). Human ORC, however,
follows an ordered pathway for the sequential addition of the
different subunits. Orc2 and Orc3 bind to each other and then
recruit Orc5. The Orc2/Orc3/Orc5 complex recruits Orc4 and
then Orc1 in an ATP-dependent process. Similar results for
human ORC have been described recently in an independent
study (8). In other eukaryotic systems examined thus far (15–
17, 41), a nucleotide requirement for complex assembly has not
been reported, although work on simian virus 40 (SV40) and
papillomavirus DNA replication has revealed that ATP pro-
motes the formation of T-antigen or E1 hexamers, respectively,
at origins of replication (42–44). Such dynamic subunit inter-
actions between the human ORC subunits suggest an addi-
tional mechanism for regulation at the level of complex assem-
bly and disassembly andmay have implications for the cell cycle
control of human ORC function in vivo.
Analysis of mutants revealed that ATP binding by Orc1 was
not essential for complex formation. ATP binding by human
Orc4 is essential for both Orc2–Orc5 as well as Orc1–Orc5
association (8). ATP binding by Orc5 is necessary for Orc2–
Orc5 assembly but is not essential forOrc1–Orc5 association in
vitro. One possible explanation is that Orc4 may require nucle-
otide binding to form productive interactions with both Orc1
and Orc5, whereas Orc1 may form nucleotide-independent
contacts with Orc5 that allow it to rescue complex formation
with an ATP-binding mutant. The requirement for ATP bind-
ing by Orc5 and Orc4 suggests that these proteins may have
flexible domains existing in multiple conformations, and the
ATP-bound form is the “active” form for complex assembly.
Two observations support this idea. Firstly, mutants of Orc4
and Orc5 that do not bind ATP are expressed very poorly in
comparison with wild type Orc4 and Orc5 in cultured human
cells, whereas the correspondingmutants ofOrc1 are expressed
similarly to wild type Orc1 (data not shown). Secondly, a three-
dimensional structure of recombinant Drosophila ORC has
been reported to assume different conformations when incu-
bated with different nucleotides, which may be attributable to
various nucleotide-dependent confirmations of the AAA
proteins (21). This result is reminiscent of other AAA protein
assemblies that exhibit different conformations in the presence
of ATP versus ADP (33, 45–50).
Mutants of Orc1, Orc4, and Orc5 predicted to disrupt ATP
hydrolysis formed complexes that were indistinguishable from
complexes containing the wild type proteins. ATPS also sup-
ported Orc2/Orc3/Orc4/Orc5 complex formation. This result
suggests that ATP hydrolysis in the complex is not required for
assembly and may perform a different function in DNA repli-
cation, such as binding Cdc6 proteins at the origins or loading
MCM proteins (22, 51). ADP does not support Orc2/Orc3/
Orc4/Orc5 complex assembly, and this result may have physi-
ological relevance. ATP hydrolysis within human ORC, per-
haps by the Orc4 subunit, may couple the ATPase activity with
the disassembly of the complex since it would adopt a non-
permissive ADP-bound conformation. If the bound ADP does
FIGURE 7. Association of Orc6 with ORC in vivo and in vitro. a, polyclonal
antibodies against Orc3 and Orc5 co-precipitate with Orc6 from HEK293
nuclear extracts. Polyclonal antibodies against Orc3 (CS1890), Orc4 (CS2100),
and Orc5 (CS1562, CS1569) were used to immunoprecipitate ORC from
HEK293 nuclear extracts. Purified rabbit IgG was used as control. The immu-
noprecipitates (I.P.)wereexamined for thepresenceofORCsubunits byWest-
ern blotting. b, monoclonal antibodies against Orc3 co-precipitate with Orc6
from HEK293 nuclear extracts. Monoclonal antibodies against Orc3 (PKS16
clone number 11) or Myc epitope (9E10) were used to immunoprecipitate
ORC from HEK293 nuclear extracts. The immunoprecipitates were examined
for the presence of ORC subunits by Western blotting. c, Orc6 interacts with
Orc3 in vitrousing aGSTpulldownassay. GSTorGST-Orc6was incubatedwith
[35S]methionine-labeled ORC subunits and washed extensively. The bound
proteins were analyzed by SDS-PAGE followed by autoradiography and
showed that Orc6 interacts specifically with Orc3 using this assay. C, purified
GST; O, GST-Orc6.
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not dissociate easily, it could inhibit the formation of active
Orc2/Orc3/Orc4/Orc5 complexes during S and G2 phases
when Orc1 is absent. ATP hydrolysis-coupled disassembly has
been reported in AAAmolecular machines whereby engage-
ment and the subsequent degradation of substrate results in
disassembly of the 26 S proteasome as part of each catalytic
cycle (52). Also, a “nucleotide-switch” mode of regulation is
seen in prokaryotic DNA replication that limits DNA replica-
tion initiation to once per cell cycle
(53, 54). ATP hydrolysis by the ini-
tiator DnaA results in the ADP-
DnaA form that accumulates for the
duration of the cell cycle, and the
next cell cycle requires new protein
synthesis to generate ATP-DnaA. It
may be that the ADP dissociation
rate controls when ORC subunits
are competent to reform the ATP-
dependent complex. Alternatively,
events during early mitosis may
reset the nucleotide-bound state of
Orc4 and Orc5, and new synthesis
of Orc1 would allow ATP-depend-
ent assembly of ORC as cells exit
mitosis before assembly of the pre-
replicative complex.
The results of the immunopre-
cipitation analysis showed that
overexpression of Orc1 in human
cells promoted association of Orc4
with the complex. Furthermore,
analysis of Orc3 immunoprecipi-
tates across S phase revealed that
association of both Orc1 and Orc4
with the coreORC (Orc2, Orc3, and
Orc5) are lost in a parallel fashion,
again supporting the view that Orc4
association is Orc1-dependent. A
similar cell cycle-dependent enrich-
ment of Orc4 with ORC has been
observed previously (35). This result
suggests that Orc1 is limiting for
complex formation in vivo and
restricts complex assembly to the
G1 phase of the cell cycle. Perhaps
one consequence of the S phase-de-
pendent degradation of Orc1 is to
couple the initiation of DNA repli-
cation to complex disassembly, thus
ensuring that pre-replicative com-
plexes cannot be formed once cells
have started DNA synthesis.
The immunofluorescence analysis
of Orc2 (30) and Orc3 (this study)
suggests a mechanism whereby ORC
subunits are released from chromatin
in a cell cycle-dependent manner.
Evidence from at least three other
reports supports a view for dynamicORC-chromatin interactions
in higher eukaryotes. ORC is progressively removed from
chromatin as the replication proceeds across the cell cycle in
Xenopus egg extracts (55), and secondly, the half-life of ORC
on sperm chromatin is decreased in an MCM-dependent
manner in vitro (56). In a third report, pre-replicative com-
plexes were assembled onto a circular plasmid in vitro, and
the analysis revealed that inhibiting MCM loading by the
FIGURE 8. Proposed model for the regulation of human ORC during the cell cycle in tumor cells. This
model has been generated based on data presented in this study as well as others (8, 30, 34, 35, 60, 61, 63, 64)
and suggests that human ORC is a dynamic complex when compared with its budding yeast counterpart.
During mitotic exit or in G1, the complex is assembled in an ATP-dependent process and binds to origins of
DNA replication in an Orc1-dependentmanner. Entry into S phase results in degradation of Orc1 by ubiquitin-
mediated proteolysis, andORC is disassembled. ConcomitantwithOrc1 destruction, Orc4 dissociates from the
core Orc2 and Orc3 complex.
HumanOrigin Recognition Complex Assembly
NOVEMBER 2, 2007•VOLUME 282•NUMBER 44 JOURNAL OF BIOLOGICAL CHEMISTRY 32381
 at Cold Spring Harbor Laboratory, on Novem
ber 7, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
addition of geminin allows the recovery of significantly
greater quantities of ORC bound to plasmid (57). All three
reports point to the fact that ORC is essential for MCM
loading; however, once MCMs are loaded, they promote the
removal of ORC from these DNA templates, most likely in
a replication-dependent process. In addition, it has been
reported for both Xenopus as well as budding yeast systems
that upon pre-replicative complex formation on DNA, the
MCM subunits are resistant to high salt washes; however,
ORC can be easily extracted under the same conditions (58,
59). In support of these observations, in human cells, Orc1
and Orc2 subunits have been shown to dissociate from chro-
matin as cells enter S phase (34, 60), and the Orc1 subunit is
subsequently degraded by a ubiquitin-mediated mechanism
(34, 35, 61). More recently, it was also demonstrated that
Orc2 localizes in a cell-cycle dependent manner at human
chromosomal origins in HeLa cells (65).
It has been shown that ATP binding by Orc1 is necessary for
its DNA binding activity in various systems (9, 17, 23). Recent
work on human ORC has shown that Walker A mutants of
Orc1, Orc4, and Orc5 have reduced DNA binding in vitro and
are unable to support sperm DNA replication in a Xenopus
cell-free system (8, 9). Surprisingly, in the study described by
Giordano-Coltart et al. (9), recombinant human ORC com-
plexes containing a mutant Orc4 subunit were purified from
insect cells. This is contradictory to our observations that imply
that it may not be possible to generate such a complex. There
are two possible explanations for this. The overexpression of
human ORC proteins in a heterologous system supports com-
plex formation due to overexpression, or alternatively, theOrc4
K73Amutant has a reduced affinity for ATP, and complex for-
mation is rescued by inclusion of millimolar concentrations of
ATP during the purification. Our results are consistent with
those reported byRanjan andGossen (8), andwewere unable to
obtain stable Orc1/Orc2/Orc3/Orc4/Orc5 complexes using
several Orc4 mutants, either by using recombinant human
ORC expressed in insect cells or by using in vitro transcribed
and translated proteins. Our studies extend a role for ATP
binding by Orc5 in complex formation, and further analysis of
thesemutants in vivowill be required to determine the extent of
their contribution in human cells.
Finally, we asked whether Orc6 was an interacting partner of
the human origin recognition complex and were able to dem-
onstrate using a number of specific antibodies that the six ORC
subunits can be co-precipitated from human nuclear extracts.
The association between the Orc6 and Orc3 subunits in vitro
may explain the binding of Orc6 with ORC in vivo, although
this complex may require additional factors or post-transla-
tionalmodifications to generate stoichiometric complexes. The
interaction between Orc6 and ORC is regulated;4 however,
these questions will be addressed in greater detail in a separate
report.
Based on the above data and other published results (6, 8, 30,
34, 35, 60, 61, 63, 64), we suggest a model to integrate our in
vitro biochemical results with those obtained from studying the
native protein complex in cultured cells, and this is summarized
in Fig. 8. We propose that Orc1/Orc2/Orc3/Orc4/Orc5 com-
plexes are formed in an ATP-dependent manner as cells exit
anaphase of mitosis, and this ATP-loaded complex binds to
chromatin in an Orc1-dependent manner to direct the forma-
tion of pre-replicative complexes. As cells enter S phase,Orc1 is
degraded, and as a result, the complexes are disassembled. An
alternate possibility is that ATP hydrolysis in the complex
converts it into the non-permissive ADP-bound form,
resulting in ejection of the Orc1 subunit from the complex,
whose degradation is a consequence, rather than a cause, of
complex disassembly. In contrast to budding yeast, the
human Orc4 protein contains an intact Walker B motif and
may be competent to hydrolyze ATP, in addition to Orc1.
Future experiments will be designed to address this possibil-
ity. Also, the availability of non-degradable Orc1 mutants
would allow us, in the future, to ascertain whether either of
these alternatives is the correct one. In the absence of Orc1,
the Orc2 and Orc3 subunits are removed from chromatin,
perhaps accompanied by Orc5 as a stable Orc2/Orc3/Orc5
subcomplex. The Orc4 subunit may be dissociated from
chromatin or may remain bound to DNA by virtue of its
DNA binding activity (62), and it may serve to mark origins
that have already fired. Toward the end of the cell cycle, Orc1
is regenerated and cooperates with Orc4 to direct the forma-
tion of new complexes and the cycle of pre-RC formation is
repeated. At present, it is not clear at what step Orc6 partic-
ipates in complex assembly, and it may be recruited in an
ATP-independent manner by Orc3. Future experiments will
be designed to specifically address the chromatin binding of
the different ORC subunits in vivo at known origins of rep-
lication across the cell cycle.
The role of ATP binding by the human origin recognition
complex offers an additional mechanism to control pre-repli-
cative complex assembly and may be intimately linked with
another regulatory mechanism unique to human cells, i.e. the S
phase-mediated degradation of the Orc1 subunit. Whether
ATP hydrolysis by the ORC subunits is involved in the disas-
sembly of the complex or in Orc1 degradation will be the focus
of future studies. These studies will lead to a better understand-
ing of the DNA binding activity of human ORC and will ulti-
mately aid the identification of endogenous DNA substrates of
this complex that may define origins of replication in human
cells.
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